DePuy Trial Daily Updates

Day Fourteen of the Kransky trial continued on with the testimony of Randy Kilburn, the worldwide vice president of marketing for DePuy.  Defense counsel Mr. Zellers finished his cross-examination of Mr. Kilburn and Plaintiff’s counsel Mr. Panish conducted a short re-direct. -Plaintiff’s counsel next called to the stand Fabrizio Billi, a Ph.D. from the Orthopedic […]

Day six of the Kransky trial continued with Plaintiff’s counsel first calling Dr. Robert Harrison, whose expertise is in occupational and environmental medicine.  Specifically, Dr. Harrison’s specialty is related to the diagnosis and treatment of toxic chemical exposures and he works at the University of California San Francisco medical center.   Dr. Harrison explained to

January 29th Morning session: -Plaintiff’s counsel continued their case by playing a video deposition excerpt of Dr. Thomas Vail, a member of the surgeon design team who helped to design the ASR and also received royalties from the sale of the device.  Dr. Vail admitted that DePuy did not notify him beforehand that they were

January 28, Morning Session: –          Plaintiff continued with the video depositions excerpts from Magnus Flett, a former DePuy employee in the marketing department who headed the failure mode and effect analyses performed on the ASR. –          An email was introduced from Chris Hunt, a bioengineer, regarding health hazard evaluations of the ASR. Q.  And he

Co-Counsel Michael Kelly, of Walkup, Melodia, Kelly & Schoenberger, delivered Plaintiff’s Opening Statement. January 25th Morning session: –          Mr. Kelly gave Plaintiff’s opening statement, walking the jury through DePuy’s original design of the ASR XL, the lack of testing done on the device before placing it on the market, and ultimately the severe harm Plaintiff